Emergent BioSolutions Inc.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We own and lease approximately 1.0 million square feet of building space for development and manufacturing, laboratories, fill/finish facility services, offices and warehouse space for the conduct of our businesses at 11 locations in North America and Europe. Properties that have been leased expire on various dates between 2026 and 2034. Principal locations include:
| Location | Use | Approximate square feet | Owned/leased | Operating Segment |
|---|---|---|---|---|
| Lansing, Michigan | Manufacturing operations, office and laboratory space. | 336,000 | Owned | Products & Services |
| Winnipeg, Manitoba, Canada | Manufacturing operations, office and laboratory space. | 160,000 (Owned); 15,800 (Leased) | Owned/Leased | Products & Services |
| Gaithersburg, Maryland | Laboratory space, office space and rental real estate. | 173,000 (Owned);11,547 (Leased) | Owned/Leased | Products & Services |
| Canton, Massachusetts | Manufacturing operations and warehouse space. | 47,000 (Owned); 27,000 (Leased) | Owned/Leased | Products & Services |
| Elkridge, Maryland | Warehouse space. | 103,182 | Leased | Products & Services |
| Rockville, Maryland | Manufacturing facilities, office and warehouse space. | 84,295 | Owned | Products & Services |
Each property is considered to be in good condition, adequate for its purpose, and suitably utilized according to the individual nature and requirements of the relevant operations. Our policy is to improve and replace property as considered appropriate to meet the needs of the individual operations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.